Group 6 Copy 327
0
    Please wait...

    About This Project

    An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan parasite Trypanosoma cruzi that results in Chagas’ disease, a neglected tropical disease (NTD). Principally spread by the kissing bug (cover image), there exists an urgent need for development of new therapeutics to replace the outdated clinically used drugs, benznidazole and nifurtimox. Our research focuses on the discovery of novel antichagasic compounds for improved medicine.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Investigating the epidemiology of elephant endotheliotropic herpesvirus in Myanmar

    Elephant endotheliotropic herpesvirus hemorrhagic disease (EEHV-HD) is the leading cause of death of young...

    Do Pacific Northwest marine mammals carry antibiotic-resistant bacteria from land animals?

    Antibiotic resistance, a global concern, is a significant health issue of animals and humans. Resistant...

    Do fungi exposed to toxic waste produce novel antimicrobial agents?

    We've discovered a few new mushrooms thriving in this harsh environment of land-disposed sewage sludge in...

    Backer Badge Funded

    A medicine project funded by 19 people